- Capital Cube•18 hours agoChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : January 19, 2017
Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- GlobeNewswire•11 days agoChemoCentryx Provides Corporate Update Including Development Strategy for Lead Programs in Rare Renal Diseases
--Company Initiates Phase III“ ADVOCATE” Clinical Trial for Complement Receptor Inhibitor Avacopan in ANCA Vasculitis; Development Path Outlined in Rare Kidney Disease for Chemokine Receptor Inhibitor‘ ...
- GlobeNewswire•16 days ago
MOUNTAIN VIEW, Calif., Jan. 04, 2017-- ChemoCentryx, Inc.,, today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 35 th Annual J.P. Morgan Healthcare ...
CCXI : Summary for ChemoCentryx, Inc. - Yahoo Finance
ChemoCentryx, Inc. (CCXI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||7.75 - 7.98|
|52 Week Range||1.92 - 9.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|